|
Helping improve quality of life with CYTOPOINT™
|
It’s an old story:
A patient with canine atopic dermatitis is itching, scratching, chewing
and then itching some more. Both the dog and the client are beside
themselves. They’re sleep-deprived. They can’t enjoy each other’s
company. And you want to help.
|
|
|
Indication: CYTOPOINT aids in the reduction of clinical signs associated with atopic dermatitis in dogs.
|
|
*Repeat administration every 4–8 weeks, as needed, in the individual patient.1
1. Data on file, Study Report No. C863R-US-12-018, Zoetis Inc.
2. Gonzales AJ, Humphrey WR, Messamore
JE, et al. Interleukin-31: its role in canine pruritus and naturally
occurring canine atopic dermatitis. Vet Dermatol. 2013;24(1):48-53. doi:10.1111/j.1365-3164.2012.01098.x.
3. Data on file, Study Report No. C362N-US-13-042, Zoetis Inc.
4. Data on file, Study Report No. C961R-US-13-051, Zoetis Inc.
All trademarks are the property of Zoetis
Services LLC. or a related company or a licensor unless otherwise noted.
©2017 Zoetis Services LLC. All rights reserved. CYT‑00244B
To opt out of future messages from DVM360 on behalf of CYTOPOINT click here.
|
|
|